Samsung Biologics strengthens U.S. presence with acquisition of GSK’s Human Genome Sciences or $280 million
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
Under the proposed terms, Vaximm would secure a $20 million upfront payment, up to $815 million tied to clinical, regulatory, and commercial milestones
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
Globally, Abbott has received reports of 736 severe adverse events linked to the issue, including seven deaths (none in the US)
Millions of stroke survivors across the world may soon have a new defense
Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion
Subscribe To Our Newsletter & Stay Updated